LADENBURG THALMANN FINANCIAL SERVICES INC. - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 17 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,000
-33.3%
9,2260.0%0.00%
Q1 2019$3,000
-25.0%
9,2260.0%0.00%
Q4 2018$4,000
+33.3%
9,2260.0%0.00%
Q3 2018$3,000
-25.0%
9,2260.0%0.00%
Q2 2018$4,0000.0%9,2260.0%0.00%
Q1 2018$4,0009,226
+2934.9%
0.00%
Q4 2017$03040.0%0.00%
Q3 2017$03040.0%0.00%
Q2 2017$0
-100.0%
3040.0%0.00%
Q1 2017$1,0003040.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,192,000$453,0000.04%
IFP Advisors, Inc 23,800$25,0000.00%
Holistic Financial Partners 1,900$1,0000.00%
Vantage Investment Advisors, LLC 6,500$2,0000.00%
WEDBUSH SECURITIES INC 20,000$8,0000.00%
US BANCORP \DE\ 40,650$15,0000.00%
WELLS FARGO & COMPANY/MN 100$00.00%
NORTHERN TRUST CORP 14,553$6,0000.00%
CREDIT SUISSE AG/ 26,500$10,0000.00%
MORGAN STANLEY 7,721$3,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders